Ensysce Biosciences

(NASDAQ) ENSC

Current Price$0.38

Market Cap$3.61M

Since IPO (2018)-100%

5 Year-100%

1 Year-87%

1 Month-29%

Ensysce Biosciences Financials at a Glance

Market Cap

$3.61M

Revenue (TTM)

$5.07M

Net Income (TTM)

$10.18M

EPS (TTM)

$-4.22

P/E Ratio

-0.09

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$0.38

Volume

7,467

Open

$0.38

Price

$0.38

Volume

7,467

Open

$0.38

Previous Close

$0.38

Daily Range

$0.35 - $0.39

52-Week Range

$0.31 - $2.75

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$0.38

Volume

7,467

Open

$0.38

Previous Close

$0.38

Daily Range

$0.35 - $0.39

52-Week Range

$0.31 - $2.75

ENSC News

Ensysce Biosciences Narrows Loss in Q2

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ensysce Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

D. Lynn Kirkpatrick, PhD

Website

www.ensysce.com

Headquarters

La Jolla, CA 92037, US

ENSC Financials

Key Financial Metrics (TTM)

Gross Margin

-33%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-294%

Return on Capital

-4%

Return on Assets

-1%

Earnings Yield

-11.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.61M

Shares Outstanding

9.28M

Volume

7.47K

Avg. Volume

5.98M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$10.24M

EBITDA

$10.15M

Operating Cash Flow

$7.81T

Capital Expenditure

$0.00

Free Cash Flow

$7.81T

Cash & ST Invst.

$4.31T

Total Debt

$306.71B

Ensysce Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.88M

+44.4%

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$3.61M

N/A

Market Cap/Employee

$515.59K

N/A

Employees

N/A

Net Income

$2.77M

+22.4%

EBITDA

$2.76M

N/A

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$4.00T

+125097535.7%

Accounts Receivable

$420.35K

+238.7%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$306.71B

+101673307.1%

Return on Assets

-1.37%

N/A

Return on Invested Capital

-3.55%

N/A

Free Cash Flow

$1.53M

-99.7%

Operating Cash Flow

$1.53M

-99.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SNGXSoligenix, Inc.

SNGXSoligenix, Inc.$0.34+0.00%

TTNPTitan Pharmaceuticals, Inc.

TTNPTitan Pharmaceuticals, Inc.$2.34-11.36%

KALAKALA BIO, Inc.

KALAKALA BIO, Inc.$0.11+3.71%

XBIOXenetic Biosciences, Inc.

XBIOXenetic Biosciences, Inc.$2.97-1.98%

QLGNQualigen Therapeutics, Inc.

QLGNQualigen Therapeutics, Inc.$3.21+5.59%

VYNEVYNE Therapeutics Inc.

VYNEVYNE Therapeutics Inc.$0.64+0.71%

KZIAKazia Therapeutics Limited

KZIAKazia Therapeutics Limited$13.39-1.83%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About ENSC

What is the current price of Ensysce Biosciences?

Ensysce Biosciences is trading at $0.38 per share.

What is the 52-week range for Ensysce Biosciences?

Over the past 52 weeks, Ensysce Biosciences has traded between $0.31 and $2.75.

How much debt does Ensysce Biosciences have?

As of the most recent reporting period, Ensysce Biosciences reported total debt of $279,947.

How much cash does Ensysce Biosciences have on hand?

Ensysce Biosciences reported $4.31M in cash and cash equivalents in its most recent financial results.

What is Ensysce Biosciences’s dividend yield?

Ensysce Biosciences does not currently have a dividend yield.

Ensysce Biosciences

Ensysce Biosciences Financials at a Glance

ENSC News

Ensysce Biosciences Narrows Loss in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ensysce Biosciences

ENSC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ensysce Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ENSC

What is the current price of Ensysce Biosciences?

What is the 52-week range for Ensysce Biosciences?

How much debt does Ensysce Biosciences have?

How much cash does Ensysce Biosciences have on hand?

What is Ensysce Biosciences’s dividend yield?

Premium Investing Services